164 related articles for article (PubMed ID: 24864169)
1. Treatment of Mycoplasma pneumoniae in pediatric lower respiratory infection.
Colin AA; Yousef S; Forno E; Korppi M
Pediatrics; 2014 Jun; 133(6):1124-5. PubMed ID: 24864169
[No Abstract] [Full Text] [Related]
2. Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.
Gilbert DN
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S121-2. PubMed ID: 18986276
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mycoplasma pneumonia: a systematic review.
Biondi E; McCulloh R; Alverson B; Klein A; Dixon A; Ralston S
Pediatrics; 2014 Jun; 133(6):1081-90. PubMed ID: 24864174
[TBL] [Abstract][Full Text] [Related]
4. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
5. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
Ouchi K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
[TBL] [Abstract][Full Text] [Related]
6. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
7. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV
Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315
[No Abstract] [Full Text] [Related]
8. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.
Cardinale F; Chironna M; Dumke R; Binetti A; Daleno C; Sallustio A; Valzano A; Esposito S
Eur Respir J; 2011 Jun; 37(6):1522-4. PubMed ID: 21632830
[No Abstract] [Full Text] [Related]
9. Macrolide Resistant Mycoplasma pneumoniae in Community Acquired Pneumonia.
Varghese SM; Kerkar VV
Indian J Pediatr; 2020 Nov; 87(11):958. PubMed ID: 32333367
[No Abstract] [Full Text] [Related]
10. Severe Mycoplasma Pneumoniae Infection in Children Admitted to Pediatric Intensive Care.
Moynihan KM; Barlow A; Nourse C; Heney C; Schlebusch S; Schlapbach LJ
Pediatr Infect Dis J; 2018 Dec; 37(12):e336-e338. PubMed ID: 29912842
[TBL] [Abstract][Full Text] [Related]
11. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
[TBL] [Abstract][Full Text] [Related]
12. Mycoplasma pneumoniae and community-acquired pneumonia.
Dey AB; Chaudhry R; Kumar P; Nisar N; Nagarkar KM
Natl Med J India; 2000; 13(2):66-70. PubMed ID: 10835852
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of Mycoplasma pneumoniae in children.
Rogozinski LE; Alverson BK; Biondi EA
Minerva Pediatr; 2017 Apr; 69(2):156-160. PubMed ID: 28178776
[TBL] [Abstract][Full Text] [Related]
14. [Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].
Gendrel D; Raymond J; Moulin F; Iniguez JL; Truong M; Ravilly S; Chaussain M; Lebon P; Kalifa G
Presse Med; 1996 May; 25(17):793-7. PubMed ID: 8762275
[TBL] [Abstract][Full Text] [Related]
15. Prolonged Mycoplasma pneumoniae infection in an elderly patient with community-acquired pneumonia.
Takahashi T; Morozumi M; Okada T; Chiba N; Asami R; Murayama SY; Ubukata K
J Infect Chemother; 2009 Aug; 15(4):243-7. PubMed ID: 19688244
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae and Mycoplasma pneumoniae.
Blasi F; Tarsia P; Aliberti S; Cosentini R; Allegra L
Semin Respir Crit Care Med; 2005 Dec; 26(6):617-24. PubMed ID: 16388430
[TBL] [Abstract][Full Text] [Related]
17. [Mycoplasma pneumoniae pneumonia].
Izumikawa K
Nihon Rinsho; 2003 Feb; 61 Suppl 2():536-41. PubMed ID: 12722276
[No Abstract] [Full Text] [Related]
18. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.
Principi N; Esposito S; Blasi F; Allegra L;
Clin Infect Dis; 2001 May; 32(9):1281-9. PubMed ID: 11303262
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
Lee H; Yun KW; Lee HJ; Choi EH
Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
[TBL] [Abstract][Full Text] [Related]
20. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
